Serina Therapeutics, Inc.

SERAMEX • USD
1.37 USD
↘ 0.05 (3.52%)🟢LIVE (AS OF 01:15 PM EST)
🟢Market: OPEN

Serina Therapeutics, Inc. (SER) is currently trading at $1.37. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place SER at a fair price relative to peers.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.48
High?$1.48
Low?$1.26
Prev. Close?$1.42
Volume?24.9K
Avg. Volume?61.6K
VWAP?$1.35
Rel. Volume?0.41x
Bid / Ask
Bid?$1.33 × 100
Ask?$1.41 × 100
Spread?$0.08
Midpoint?$1.37
Valuation & Ratios
Market Cap?37.7M
Shares Out?25.4M
Float?7.2M
Float %?48.2%
P/E Ratio?N/A
P/B Ratio?2.71
EPS?-$1.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
Employees
16
Market Cap
36.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-03-27
Address
601 GENOME WAY
HUNTSVILLE, AL 35806
Phone: (256) 327-9630
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.76Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.65%Low
Short Interest?46.8K
Days to Cover?1.0
Free Float7.2M
Avg Daily Volume58.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?4.62Strong
Quick Ratio?4.62Strong
Cash Ratio?4.28Strong
Debt/Equity?0.23Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.71CHEAP▾
P/S?
Peers
100
S&P
3
301.83HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
171.99HIGH▾
Returns & Efficiency
ROE?
S&P
3
-196.6%WEAK▾
ROA?
S&P
3
-125.1%WEAK▾
Cash Flow & Enterprise
FCF?$-22836000
Enterprise Value?$21.5M
Fundamentals ratios updated end of day